What is the official website of AREA 23 on Hudson | An IPG Health Company ?

The official website of AREA 23 on Hudson | An IPG Health Company is https://www.area23onhudson.com/.

What is AREA 23 on Hudson | An IPG Health Company's cybersecurity risk score?

AREA 23 on Hudson | An IPG Health Company has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has AREA 23 on Hudson | An IPG Health Company experienced?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has AREA 23 on Hudson | An IPG Health Company been affected by any supply chain cyber incidents ?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does AREA 23 on Hudson | An IPG Health Company have SOC 2 Type 1 certification ?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company is not certified under SOC 2 Type 1.

Does AREA 23 on Hudson | An IPG Health Company have SOC 2 Type 2 certification ?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company does not hold a SOC 2 Type 2 certification.

Does AREA 23 on Hudson | An IPG Health Company comply with GDPR ?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company is not listed as GDPR compliant.

Does AREA 23 on Hudson | An IPG Health Company have PCI DSS certification ?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company does not currently maintain PCI DSS compliance.

Does AREA 23 on Hudson | An IPG Health Company comply with HIPAA ?

According to Rankiteo, AREA 23 on Hudson | An IPG Health Company is not compliant with HIPAA regulations.

Does AREA 23 on Hudson | An IPG Health Company have ISO 27001 certification ?

According to Rankiteo,AREA 23 on Hudson | An IPG Health Company is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does AREA 23 on Hudson | An IPG Health Company operate in ?

AREA 23 on Hudson | An IPG Health Company operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does AREA 23 on Hudson | An IPG Health Company have ?

AREA 23 on Hudson | An IPG Health Company employs approximately 73 people worldwide.

Does AREA 23 on Hudson | An IPG Health Company own any subsidiaries ?

AREA 23 on Hudson | An IPG Health Company presently has no subsidiaries across any sectors.

How many LinkedIn followers does AREA 23 on Hudson | An IPG Health Company have ?

AREA 23 on Hudson | An IPG Health Company's official LinkedIn profile has approximately 3,596 followers.

What is the NAICS classification code for AREA 23 on Hudson | An IPG Health Company ?

AREA 23 on Hudson | An IPG Health Company is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does AREA 23 on Hudson | An IPG Health Company have a Crunchbase profile ?

No, AREA 23 on Hudson | An IPG Health Company does not have a profile on Crunchbase.

Does AREA 23 on Hudson | An IPG Health Company have a LinkedIn profile ?

Yes, AREA 23 on Hudson | An IPG Health Company maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/area23onhudson.

How many cybersecurity incidents has AREA 23 on Hudson | An IPG Health Company experienced ?

As of August 3, 2026, Rankiteo reports that AREA 23 on Hudson | An IPG Health Company has not experienced any cybersecurity incidents.

How many peer or competitor companies does AREA 23 on Hudson | An IPG Health Company have ?

AREA 23 on Hudson | An IPG Health Company has an estimated 5,720 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

AHIHC

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

AREA 23 on Hudson | An IPG Health Company Vendor Cyber Rating & Cyber Score

area23onhudson.com

Add Your Compliance Badge

AREA 23 on Hudson, an IPG Health Company, is a team of creative problem-solvers who don’t believe in a cookie-cutter approach to medical communications. Driven by a shared vision with our client partners, we innovate solutions to create lasting impact with HCPs. We don’t just make great work; we specialize in building work that meaningfully changes behavior. Compelling messaging, thought leadership engagement, and marketing innovation—that’s the construct that propels us higher than the rest, the combination that will set your brand apart. Looking to explore better ways to shape and disseminate your pharmaceutical story? Looking to join an agency family with a unique perspective? Contact us via LinkedIn or at 914-332-1515 Follow us

AHIHC A.I CyberSecurity Scoring

Scoring History

AHIHC

AREA 23 on Hudson | An IPG Health Company CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

AHIHC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for AHIHC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AREA 23 on Hudson | An IPG Health Company in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for AREA 23 on Hudson | An IPG Health Company in 2026.

Incident Types AHIHC vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AREA 23 on Hudson | An IPG Health Company in 2026.

Incident History - AHIHC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

AREA 23 on Hudson | An IPG Health Company Subsidiaries

AHIHC

Pharmaceutical Manufacturing

Website: https://www.area23onhudson.com/

Company Size: 73

IPG Health Medical CommunicationsPharmaceutical Manufacturing

IPG HealthAdvertising Services

FCB Health New York | An IPG Health CompanyAdvertising Services

McCann Health Brazil | An IPG Health CompanyAdvertising Services

McCann HealthAdvertising Services

SOLVE(D) | An IPG Health CompanyAdvertising Services

Studio Rx | An IPG Health CompanyAdvertising Services

McCann Health London | An IPG Health CompanyAdvertising Services

FCBCURE | An IPG Health CompanyAdvertising Services

Rise & Run | An IPG Health CompanyAdvertising Services

McCann Health New Jersey, an IPG Health CompanyAdvertising Services

FCB Health London | An IPG Health CompanyAdvertising Services

Mosaic Group | An IPG Health CompanyAdvertising Services

McCann Health Managed Markets | An IPG Health CompanyAdvertising Services

NEON | An IPG Health CompanyAdvertising Services

McCann Health Canada | An IPG Health CompanyAdvertising Services

YuzuYello | an IPG Health CompanyAdvertising Services

McCANN Health Paris | An IPG Health CompanyAdvertising Services

FCB Health Canada | An IPG Health CompanyAdvertising Services

IPG Health Global Market Access Pharmaceutical Manufacturing

IPG Health FrankfurtAdvertising Services

BX Brand Experience Design Group | An IPG Health CompanyDesign Services

McCann Global Health | An IPG Health CompanyAdvertising Services

Humancare | An IPG Health CompanyAdvertising Services

McCann Health Medical CommunicationsWellness and Fitness Services

CMC Connect | An IPG Health CompanyPharmaceutical Manufacturing

Caudex | An IPG Health CompanyPharmaceutical Manufacturing

ProHealth | An IPG Health CompanyAdvertising Services

Trio | An IPG Health CompanyPharmaceutical Manufacturing

Complete HealthVizion | An IPG Health CompanyPharmaceutical Manufacturing

CMC Affinity | An IPG Health CompanyPharmaceutical Manufacturing

Complete Regulatory | An IPG Health CompanyPharmaceutical Manufacturing

Loading…

AREA 23 on Hudson | An IPG Health Company Similar Companies

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Loading…

NEWS

AREA 23 on Hudson | An IPG Health Company CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

June 21, 2021 07:00 AM

FCB Health Network’s AREA 23 Wins Cannes Lions Pharma Grand Prix with SICK BEATS Campaign

NEW YORK, June 21 (Korea Bizwire) — AREA 23, an FCB Health Network company, swept the Cannes Lions health awards circuit,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-18577

SUMMARY

An incomplete patch for CVE-2026-18556 allows for authentication bypass and account takeover in N-central Versions through 2026.3.1

Published

Date2026-08-02

Updated

Date2026-08-02

RISK INFORMATION (Score: )

cvss4

Base Score: 8.2

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:L/SI:L/SA:L/E:A/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-10848

SUMMARY

The OCPP 1.6 client in subsys/net/lib/ocpp parsed inbound WAMP RPC frames in parse_rpc_msg() (subsys/net/lib/ocpp/ocpp_j.c) using a hand-rolled helper, extract_string_field(), that copied the message's uid and action fields with strncpy(out_buf, token + 1, outlen - 1) and then scanned the result with strchr(out_buf, '"'). Because strncpy does not NUL-terminate the destination when the source is at least outlen - 1 (127) bytes long, the subsequent strchr reads past the 128-byte destination buffer into adjacent stack memory; if a " byte is found beyond the buffer, a one-byte out-of-bounds NUL write also occurs. A related defect in extract_payload() runs strchr/strrchr over the receive buffer, which may not be NUL-terminated when a maximal-length frame fills it. The parsed bytes come directly from the OCPP central-system server over a websocket: the reader thread fills recv_buf via websocket_recv_msg() and calls parse_rpc_msg() on each inbound DATA frame (subsys/net/lib/ocpp/ocpp.c). A malicious or compromised central server, or an on-path attacker (OCPP is commonly deployed over plain ws://), can send an RPC frame whose uid or action field is 127+ bytes with no closing quote, triggering the out-of-bounds access. The primary impact is a remotely triggerable denial of service: the unbounded scan can fault on an unmapped page, and the stray NUL write can corrupt adjacent stack state. The over-read data is not reflected to the peer, so disclosure is limited. The feature is EXPERIMENTAL and must be explicitly enabled (CONFIG_OCPP). The fix replaces the manual parser with the bounds-respecting json_mixed_arr_parse() and copies the extracted uid with an explicitly NUL-terminated buffer, eliminating both over-reads.

Published

Date2026-08-02

Updated

Date2026-08-02

RISK INFORMATION (Score: 7)

cvss3

Base Score: 7.0

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H

Impact Score

4.7

Exploitability

2.2

REFERENCES

CVE-2026-9856

SUMMARY

A vulnerability in huggingface/transformers versions <=5.8.0.dev0 allows an attacker to perform arbitrary file writes via path traversal. The issue resides in the `save_pretrained()` methods of `PreTrainedTokenizerBase` and `ProcessorMixin`, where keys from the `chat_template` dictionary are used directly as filenames without proper validation. An attacker can exploit this by publishing a malicious Hugging Face Hub repository with a crafted `tokenizer_config.json` file. When a victim downloads and saves the tokenizer or processor, the attacker-controlled keys can escape the intended save directory, enabling arbitrary file writes with attacker-controlled content. This vulnerability affects multiple processors inheriting from `ProcessorMixin`, including Idefics, Florence, Gemma, Phi, and Qwen-VL.

Published

Date2026-08-02

Updated

Date2026-08-02

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:L

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-65321

SUMMARY

PyAthena prior to 3.35.4 contains a sql injection vulnerability that allows unauthenticated attackers to inject arbitrary SQL by exploiting improper quote-escaping in DefaultParameterFormatter.format(), which routes DELETE and CTAS statements to the _escape_hive function that backslash-escapes single quotes rather than doubling them. Because Athena and Trino do not treat backslashes as escape characters inside string literals, attacker-supplied input such as a single quote followed by SQL syntax causes the parser to terminate the string literal prematurely, enabling data exfiltration via UNION SELECT, execution of destructive statements, and attacker-controlled CTAS destination and content.

Published

Date2026-08-02

Updated

Date2026-08-02

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-10774

SUMMARY

Zephyr's Bluetooth Mesh subnet key management leaks one PSA Crypto key slot on every subnet-key teardown. In subsys/bluetooth/mesh/subnet.c, net_keys_create() imports the Private Beacon Key into a PSA key slot under CONFIG_BT_MESH_PRIV_BEACONS (enabled by default), but subnet_keys_destroy() guarded the matching psa_destroy_key() with CONFIG_BT_MESH_V1d1. That Kconfig symbol was removed when explicit Mesh 1.0.1 support was dropped, so the destroy branch became permanently dead code and the import is never balanced by a destroy. The imbalanced teardown is reached every time subnet keys are destroyed: deleting a subnet (Config Server NetKey Delete), completing a Key Refresh Procedure (which retires the old key set), and resetting/re-provisioning the node. The over-the-air triggers are processed only under the node's device key, so they are exercisable by the provisioner or network administrator that owns the node, reachable over the Bluetooth Mesh network. With the default CONFIG_MBEDTLS_PSA_KEY_SLOT_COUNT of 16, repeated add/delete or key-refresh cycles exhaust the shared PSA key-slot pool after roughly a dozen rounds. Once exhausted, bt_mesh_private_beacon_key() and thus subnet creation fail: the node can no longer add subnets or complete key refresh, and other PSA crypto consumers on the device may be starved, until the device is rebooted. The fix aligns the destroy guard with the import guard (CONFIG_BT_MESH_PRIV_BEACONS) so each slot is freed.

Published

Date2026-08-02

Updated

Date2026-08-02

RISK INFORMATION (Score: 2.4)

cvss3

Base Score: 2.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

0.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…